Bak Expression and Cell Death Occur in Peritumorous Tissue but not in Pancreatic Cancer Cells

Journal of Gastrointestinal Surgery

Volumn 3, Issue 1, 1999, Pages 74-81

  Graber, Hans U ^a   Friess, Helmut ^a   Zimmermann, Arthur ^b   Korc, Murray ^d   Adler, Guido ^c   Schmid, Roland ^c   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Bak expression; Carcinogenesis; In situ hybridization; Pancreatic cancer

Indexed keywords

BAK1 PROTEIN, HUMAN; DNA FRAGMENT; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN BAK; PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; CELL TRANSFORMATION; CHILD; CYTOLOGY; DENSITOMETRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NORTHERN BLOTTING; PANCREAS; PANCREAS TUMOR; PATHOLOGY;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BLOTTING, NORTHERN; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CHILD; DENSITOMETRY; DNA FRAGMENTATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER;

EID: 0032600214     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(99)80012-2     Document Type: Article

References (26)

1. Fisher DE. Apoptosis in cancer therapy: Crossing the threshold. Cell 1994;78:539-542.
2. Yin XM, Oltval ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodirnerization with Bax [see comments]. Nature 1994;369: 321-323.
3. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
4. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB, bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
5. Chittenden T, Harrington EA, O'Conner R, Flemington C, Lutz RJ, Evan GI, Guild BC. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995;374:733-736.
6. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995;374:736-739.
7. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
8. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, Chinnadurai G. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 1995;11:1921-1928.
9. Chittenden T, Flemington C, Houghton AB, Ebb RG, Gallo GJ, Elangovan B, Chinnadurai G, Lutz RJ. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBOJ 1995;14:5S89-S596.
10. Bornman PC, Krige JEJ, Prognosis in the carcinoma of pancreas. Dig Surg 1994;11:342-345.
11. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284-2303.
12. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchler M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992;90: 1352-1360.
13. Ebert M, Yokoyama M, Kobrin MS, Friess H, Lopez ME, Buchler MW, Johnson GR, Korc M. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994;54:3959-3962.
14. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI, Korc M. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-1856.
15. Hermanek P, Scheibe O, Spiessl B, Wagner G. TNM Klassifikation maligner Tumoren. New York Springer-Verlag, 1987.
16. Graber HU, Müller CF, Vandevelde M, Zurbriggen A. Restricted infection with canine distemper virus leads to down-regulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol (Berl) 1995;90:312-318.
17. Guo XZ, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Büchler MW. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastasis. Cancer Res 1996;56:4876-4880.
18. Kashiwagi M, Friess H, Uhl W, Graber H, Duarte R, Zimmermann A, Büchler MW. Phospholipase A2 isoforms are altered in chronic pancreatitis. Ann Surg 1998;227:220-228.
19. Friess H, Cantero D, Graber H, Tang WH, Guo XZ, Kashiwagi M, Zimmermann A, Gold LI, Korc M, Büchler MW. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Gastroenterology 1997;113:904-913.
20. Guo XZ, Friess H, Maurer C, Tang WH, Zimmermann A, Naef M, Graber HU, Korc M, Büchler MW. KAI1 is unchanged in metastatic and non-metastatic esophageal and gastric cancers. Cancer Res 1998;58:753-758.
21. Lu Z, Friess H, Graber HU, Guo XZ, Schilling M, Zimmermann A, Korc M, Büchler MW. The presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage. Dig Dis Sci 1997;42:2054-2063.
22. Friess H, Zhao L, Riesle E, Uhl W, Bründler MA, Horvath L, Gold LI, Korc M, Büchler MW. Enhanced expression of TGF-βs and their receptors in human acute pancreatitis. Ann Surg 1998;227:95-104.
23. Deflorin J, Friess H, Schobinger ST, Bründler MA, Schilling M, Naef M, Korc M, Büchler MW. Overexpression of the epidermal growth factor receptor family in gastric cancer suggests a role in tumor pathogenesis. Dig Surg 1997;14:252-259.
24. Tukey JW. Explanatory data analysis. Reading, Mass.: Addison-Wesley Publishing, 1977.
25. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996;56:2422-2427.
26. Krajewski S, Krajewska M, Reed JC. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res 1996;56: 2849-2855.